tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Asthika Goonewardene, 12 are a HOLD (12.9%), 81 are a BUY (87.1%).
Analyst Asthika Goonewardene works at TRUIST with a stock forecast success ratio of 33.51% fulfilled within 81.8 days on average.
Asthika Goonewardene’s has documented 184 price targets and ratings displayed on 20 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on GMAB, Genmab AS at 26-Mar-2024.
Analyst best performing recommendations are on IMGN (IMMUNOGEN).
The best stock recommendation documented was for IOVA (IOVANCE BIOTHERAPEUTICS) at 12/27/2023. The price target of $17 was fulfilled within 62 days with a profit of $9.77 (135.13%) receiving and performance score of 21.8.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
8
$4.02 (101.01%)
9
1 months 20 days ago
0/3 (0%)
$2.86 (55.64%)
Buy
10
$6.02 (151.26%)
12
2 months 28 days ago
1/7 (14.29%)
$6.91 (223.62%)
28
Buy
10
$6.02 (151.26%)
12
2 months 28 days ago
0/5 (0%)
$6.91 (223.62%)
Buy
18
3 months 8 days ago
2/9 (22.22%)
$12.2 (210.34%)
94
Hold
35
3 months 11 days ago
1/2 (50%)
$19.71 (128.91%)
6
Which stock is Asthika Goonewardene is most bullish on?
Which stock is Asthika Goonewardene is most reserved on?
What Year was the first public recommendation made by Asthika Goonewardene?
